Herbal Monograph
Eleuthero
Eleutherococcus senticosus (Rupr. & Maxim.) Maxim.
Araliaceae
Foundational adaptogen that builds resilience to stress, enhances endurance, ...
Overview
Plant Description
Deciduous, thorny shrub, 2-3 m tall (occasionally reaching 5-7 m under favorable conditions). Stems erect to arching, densely covered with thin, downward-pointing thorns (prickles) that are fine and bristle-like, giving rise to the species epithet senticosus ('thorny') and common names such as 'devil's bush.' Bark light gray on older stems. Leaves compound, palmate, with 3-5 (usually 5) elliptic to obovate leaflets, 5-13 cm long, arranged digitately on a long petiole; margins doubly serrate; upper surface dark green and glabrous; lower surface paler with pubescence along the veins. Inflorescence a solitary or clustered umbel on long peduncles arising from the terminal or upper axillary buds. Flowers small, unisexual or bisexual (plants polygamo-dioecious); male flowers yellowish or pale violet; female and bisexual flowers pale purple to violet. Petals 5, stamens 5, ovary inferior, 5-carpellate, with 5 fused styles. Fruit a globose, black, fleshy drupe, 7-10 mm in diameter, borne in dense clusters, containing 5 pyrenes (seeds). Root system consists of a stout, woody, cylindrical rhizome with abundant branching roots, light brown to yellowish-brown externally, pale yellow internally, with a slightly pungent, aromatic odor and a mildly sweet then bitter taste.
Habitat
Native to mixed and coniferous mountain forests, thickets, and forest margins. Grows in the understory of cedar, spruce, and broadleaf forest. Prefers moist, well-drained, humus-rich soils with partial shade. Tolerates a range of soil types, including sandy and loamy soils, pH 5.0-7.0. Found at elevations from sea level to approximately 800 m in the northern parts of its range and up to 2,000 m in China. Cold-hardy to USDA Hardiness Zone 3 (-40C). Thrives in cool, continental climates with adequate moisture.
Distribution
Native to the Russian Far East (Primorsky Krai, Khabarovsk Krai, Amur Oblast, Sakhalin), northeastern China (Heilongjiang, Jilin, Liaoning, Hebei, Shanxi provinces), the Korean Peninsula, Hokkaido (northern Japan), and parts of Mongolia. The largest natural stands are found in the Sikhote-Alin mountain range of the Russian Far East. Extensively studied and commercially harvested in Russia since the 1950s. Cultivated in Russia, China, Korea, Japan, and to a smaller extent in North America and Europe for the medicinal plant market. Wild populations have declined in some areas due to overharvesting, prompting cultivation efforts.
Parts Used
Root and rhizome (Eleutherococci radix et rhizoma)
Preferred: Dried root/rhizome for decoctions; standardized dry or liquid extract (most common in clinical use and research); tincture (hydroethanolic extract); powdered root in capsules or tablets
The root and rhizome are the primary medicinal parts recognized by the European Pharmacopoeia (Eleutherococci radix), WHO monographs, and the Commission E. The Russian State Pharmacopoeia and the body of Soviet-era research use the root and rhizome as the standard drug. The European Pharmacopoeia monograph specifies a minimum content of 0.08% eleutherosides expressed as eleutheroside B and eleutheroside E. The root contains the highest concentration of eleutherosides and other bioactive constituents.
Stem bark (Acanthopanacis senticosi cortex — ci wu jia)
Preferred: Dried stem bark for decoctions; granules; tablets
The stem bark is listed in the Chinese Pharmacopoeia (Pharmacopoeia of the People's Republic of China) under the name ci wu jia (刺五加). Used in traditional Chinese medicine for rheumatic conditions, to strengthen sinews and bones, and as a qi and yang tonic. Contains eleutherosides and other lignans, though in different proportions than the root. Some commercial products, particularly those of Chinese origin, may use stem bark rather than root. The stem bark is considered acceptable but not equivalent to the root in Western and Russian practice.
Key Constituents
Phenylpropanoid glycosides (lignans and their glycosides)
The phenylpropanoid glycosides, particularly eleutherosides B and E, are considered the primary bioactive constituents responsible for eleuthero's adaptogenic activity. These compounds modulate the hypothalamic-pituitary-adrenal (HPA) axis, enhance stress resistance, and support immune function. Eleutheroside B (syringin) has been shown to enhance adrenal cortex function and modulate cortisol release under stress. Eleutheroside E demonstrates significant anti-fatigue activity and immunostimulation. The European Pharmacopoeia requires a combined minimum content of 0.08% eleutherosides B and E for quality compliance. Panossian and Wikman (2009) provided a comprehensive review of the molecular mechanisms of these compounds in the adaptogenic response, demonstrating their roles in modulating stress-activated protein kinases, heat shock proteins (particularly Hsp70), cortisol, and nitric oxide.
Triterpenoid saponins
The triterpenoid saponins contribute to eleuthero's anti-inflammatory, hepatoprotective, and immunomodulatory properties. Unlike Panax ginseng, which contains dammarane-type ginsenosides, eleuthero contains oleanane-type saponins, reinforcing the pharmacological distinction between these two Araliaceae members. The saponin fraction supports the overall tonic and restorative profile of the root extract.
Polysaccharides
The polysaccharide fraction is responsible for much of eleuthero's immunomodulatory activity. Wagner et al. (1985) demonstrated that eleuthero polysaccharides stimulate granulocyte and macrophage function and enhance phagocytosis. Steinmann et al. (2001) showed in vitro immunostimulatory effects including induction of IL-1, IL-6, and TNF-alpha from macrophages. The polysaccharides are best extracted by water or low-alcohol preparations (decoctions, aqueous extracts). Hydroalcoholic extracts capture these less efficiently than aqueous preparations, which has implications for preparation selection.
Coumarins
The coumarin fraction contributes modestly to the overall anti-inflammatory profile of eleuthero. Isofraxidin is the most pharmacologically characterized coumarin in eleuthero and demonstrates meaningful anti-inflammatory activity in preclinical models. Coumarin content is not high enough to raise anticoagulant concerns at standard doses.
Other constituents
Minor constituent classes that contribute to the overall phytochemical complexity and antioxidant capacity of eleuthero preparations. The phenolic acid fraction provides general antioxidant support. These constituents are not considered primary drivers of the adaptogenic or immunomodulatory activity.
Herbal Actions
The defining and most thoroughly documented action of eleuthero. The concept of adaptogens was formally articulated by Brekhman and Dardymov (1969) based largely on research with E. senticosus. An adaptogen must: (1) be nonspecific in its enhancement of the body's resistance to a wide range of stressors; (2) have a normalizing influence on physiology regardless of the direction of deviation from normal; and (3) be nontoxic and produce minimal disturbance to normal physiological function. Eleuthero meets all three criteria. Its adaptogenic activity involves modulation of the HPA axis, regulation of key stress mediators (cortisol, catecholamines, heat shock proteins, nitric oxide), and enhancement of cellular energy metabolism. Panossian and Wikman (2009, 2010) elucidated the molecular mechanisms, demonstrating that adaptogens including eleuthero regulate the expression of Hsp70, cortisol, and stress-activated c-Jun N-terminal protein kinase (JNK1).
[2, 3, 15, 16, 17]Eleuthero demonstrates significant modulation of innate and adaptive immune function. Polysaccharides (eleutherans) stimulate macrophage activation, enhance phagocytosis, and increase natural killer (NK) cell activity. Eleutheroside B and E modulate cytokine production. Clinical studies have demonstrated enhanced immune parameters in healthy subjects and in those under stress. Bohn et al. (1987) observed increased numbers and activity of immunocompetent cells (T-lymphocytes, particularly helper/inducer T-cells) in a double-blind trial of healthy volunteers. The immunomodulatory effect is bidirectional: enhancing suppressed immune function while modulating overactive immune responses, consistent with the adaptogenic paradigm.
[2, 7, 18, 19]A general tonic that enhances overall vitality, work capacity, and mental performance, particularly during convalescence, fatigue states, and periods of reduced efficiency. Commission E approved eleuthero as a tonic for invigoration and fortification during fatigue, declining capacity for work and concentration, and convalescence. The tonic action is distinct from acute stimulation: eleuthero does not produce jitteriness, overstimulation, or a crash, but rather a sustained enhancement of resilience and functional capacity over weeks to months of regular use.
[1, 2, 3]Enhances physical and mental endurance and counters fatigue. Extensive Soviet-era research documented improved work capacity in soldiers, athletes, factory workers, and cosmonauts. Asano et al. (1986) demonstrated improved maximal work capacity and enhanced oxygen metabolism in a clinical trial of recreational athletes. The anti-fatigue mechanism involves enhanced mitochondrial efficiency, improved oxygen utilization, and modulation of stress hormones. Modern research by Schaffler et al. (2013) confirmed sustained attention and concentration enhancement.
[2, 6, 8, 15]Increases nonspecific resistance to physical, chemical, and biological stressors. Eleuthero modulates the stress response by regulating the HPA axis, preventing excessive cortisol elevation, and supporting adrenal function under chronic stress. Facchinetti et al. (2002) demonstrated reduced cardiovascular stress response in a clinical study. The anti-stress action underlies the plant's traditional use for supporting individuals undergoing prolonged physical or psychological stress.
[9, 15, 16]Mild cognitive-enhancing effects observed in clinical and preclinical studies. Improves attention, concentration, and mental clarity under stress and fatigue. Supports cerebral circulation and neuronal metabolism. The cognitive benefit is most apparent during periods of stress or fatigue rather than at baseline. Not a primary nootropic but provides meaningful cognitive support as part of its broader adaptogenic profile.
[2, 6]Mild blood glucose-lowering effect observed in some preclinical studies and traditional use. Eleuthero may improve insulin sensitivity and glucose metabolism. Not a primary hypoglycemic agent, but the effect may be clinically relevant in metabolic support formulas and warrants consideration in diabetic patients on glucose-lowering medication.
[2, 13]Therapeutic Indications
endocrine-metabolic
Stress-related fatigue and reduced work capacity
The primary indication supported by Commission E, EMA, and WHO. Eleuthero is approved for 'sensations of weakness, exhaustion, tiredness, and loss of concentration, and during convalescence' (Commission E). The EMA traditional use registration covers 'symptoms of asthenia such as fatigue and weakness.' Extensive Soviet-era research by Brekhman and colleagues documented improved work capacity in diverse populations (factory workers, athletes, military personnel, miners). Schaffler et al. (2013) conducted a modern phase III RCT demonstrating significant improvement in sustained attention and mental fatigue in 190 patients over 12 weeks. The WHO monograph recognizes eleuthero as a prophylactic and restorative tonic for enhancing mental and physical capacities in cases of weakness, exhaustion, and tiredness, and during convalescence.
[1, 2, 3, 6, 15]HPA axis dysfunction and chronic stress adaptation
Eleuthero modulates the hypothalamic-pituitary-adrenal (HPA) axis, supporting healthy cortisol rhythms and preventing maladaptive stress responses. Panossian and Wikman (2009, 2010) elucidated the molecular mechanisms: adaptogens including eleuthero modulate key stress mediators including cortisol, nitric oxide, stress-activated protein kinase JNK1, and molecular chaperones (Hsp70 and Hsp72). The plant supports adrenal function without directly stimulating cortisol production, making it suitable for both hyper- and hypo-cortisol states. Clinically used for individuals experiencing the effects of chronic, unrelenting stress who present with fatigue, cognitive fog, disrupted sleep-wake cycles, and reduced resilience.
[9, 13, 16, 17]Convalescence and recovery from illness
Commission E and WHO recognize eleuthero for use during convalescence. The plant supports recovery from acute illness, surgery, or prolonged debility by enhancing immune function, restoring vitality, and improving appetite and energy. Particularly indicated when convalescence is prolonged, when the patient fails to recover expected vitality after illness, or when fatigue persists after resolution of the primary condition. The combined adaptogenic, immunomodulatory, and tonic actions provide a comprehensive convalescent support profile.
[1, 2, 3, 12]Immune System
Recurrent infections and immune deficiency
Eleuthero enhances both innate and adaptive immune function. Bohn et al. (1987) demonstrated increased numbers and activity of immunocompetent cells (particularly T-helper lymphocytes) in a double-blind trial of 36 healthy volunteers after 4 weeks of eleuthero extract. Wagner et al. (1985) showed that eleuthero polysaccharides stimulate macrophage phagocytic activity and modulate cytokine production. Clinically indicated for patients with recurrent upper respiratory infections, chronic fatigue with immune compromise, and stress-related immunosuppression. The immunostimulatory effect is particularly relevant for prevention rather than acute treatment of infections.
[2, 7, 18, 19]Upper respiratory tract infection prevention
Prophylactic use to reduce the frequency and severity of upper respiratory infections, particularly during cold and flu season. The combined immunostimulatory and adaptogenic actions reduce susceptibility to infection during periods of stress, overwork, and environmental challenge. Soviet-era prophylactic studies in large industrial and military populations documented reduced incidence of respiratory infections and sick days. Shadrin et al. (1986) studied eleuthero as an immunostimulant in a large population study and found reduced incidence of pneumonia and respiratory infections.
[2, 7]Nervous System
Mental fatigue and impaired concentration
Eleuthero improves cognitive function under conditions of stress and fatigue. Schaffler et al. (2013) demonstrated significant improvement in sustained attention capacity in a phase III RCT of 190 patients with asthenia. The nootropic effect is secondary to the adaptogenic modulation of stress hormones and enhancement of cerebral energy metabolism. Particularly indicated for students during examination periods, professionals under deadline pressure, and any individual experiencing cognitive decline related to prolonged stress or fatigue. The enhancement is modest and sustained rather than dramatic and acute, consistent with the tonic nature of the herb.
[2, 6, 12]Neurasthenia and nervous exhaustion
Traditional use in both Russian and Chinese medicine for nervous exhaustion, insomnia with fatigue, and reduced mental resilience. In TCM, ci wu jia calms the shen (spirit) and is used for insomnia, dream-disturbed sleep, and poor memory associated with Kidney and Heart qi deficiency. In Russian phytotherapy, eleuthero was used extensively for neurasthenia — a condition characterized by chronic fatigue, irritability, poor concentration, and somatic complaints attributed to nervous exhaustion. The gentle, sustaining tonic quality of eleuthero distinguishes it from stimulant approaches to nervous exhaustion.
[12, 13, 14]Cardiovascular System
Stress-related cardiovascular symptoms
Eleuthero modulates cardiovascular responses to stress. Facchinetti et al. (2002) demonstrated reduced cardiovascular stress response in a clinical study of healthy volunteers. Preclinical research has shown cardioprotective effects, blood pressure modulation, and improved cardiac efficiency under stress. Eleuthero may help normalize blood pressure in both hypotensive and hypertensive states (biphasic/normalizing effect), consistent with its adaptogenic nature. Used traditionally in Russian medicine for hypotension with fatigue.
[2, 9, 13]Musculoskeletal System
Athletic performance and exercise recovery
Eleuthero has been widely used to enhance athletic performance and accelerate recovery from intense exercise. Asano et al. (1986) demonstrated improved maximal work capacity (increase in VO2max) and enhanced oxygen utilization in a double-blind, crossover trial of recreational athletes. Soviet sports medicine research documented improved endurance, strength, and recovery in competitive athletes. However, results have been inconsistent in Western clinical trials. Dowling et al. (1996) did not find significant ergogenic effects in a well-designed trial of endurance cyclists. The overall evidence suggests modest benefits, particularly for submaximal sustained exercise and recovery, rather than dramatic ergogenic effects.
[2, 8, 10]Energetics
Temperature
warm
Moisture
slightly moist
Taste
Tissue States
cold/depression, atrophy
In traditional Western herbal energetics, eleuthero is classified as gently warming and slightly moist. It is specifically indicated for conditions arising from cold/depression tissue states — depletion, chronic fatigue, adrenal insufficiency, and lowered vitality — and atrophy tissue states — long-term debility, wasting, and convalescence. The warming quality is mild compared to Panax ginseng; eleuthero's warmth is gentle and sustaining rather than intensely heating. The sweet taste reflects its tonic, nourishing nature. The slight bitterness contributes a mild stimulating quality. In TCM, ci wu jia is classified as warm, acrid, and slightly bitter, entering the Spleen, Kidney, and Heart channels. It supplements qi, strengthens the Spleen, tonifies the Kidney, calms the shen (spirit), and invigorates blood. Unlike Asian ginseng, eleuthero is considered safe for long-term use without concern for overstimulation in most constitutions. It is more appropriate for individuals with mixed or deficient constitutions than for those with significant heat or excess conditions. Combines well with other adaptogens such as Rhodiola rosea (cooling, stimulating), Schisandra chinensis (astringent, hepatoprotective), and Glycyrrhiza glabra (moistening, harmonizing).
Traditional Uses
Russian and Soviet phytotherapy
- Adaptogen for increasing nonspecific resistance to stress (physical, chemical, biological)
- Tonic for fatigue, reduced work capacity, and debility
- Enhancement of physical and mental performance in athletes, soldiers, cosmonauts, and industrial workers
- Convalescence after acute illness, surgery, or trauma
- Prophylaxis against upper respiratory infections in industrial populations
- Radiation protection (adjunct for workers exposed to ionizing radiation)
- Neurasthenia, nervous exhaustion, and insomnia of debility
- Enhancement of immune function in immunocompromised patients
- Adjunct in cancer treatment to improve quality of life and immune function
"The research program on E. senticosus was initiated by Brekhman in the 1950s at the Far East Scientific Center of the Academy of Sciences of the USSR in Vladivostok. Brekhman sought a substitute for the rare and expensive Panax ginseng, screening over 4,000 plant species before focusing on eleuthero as the most promising adaptogenic candidate. Over the following decades, more than 1,000 pharmacological and clinical studies were conducted in the Soviet Union. Large-scale prophylactic trials involved tens of thousands of factory workers, soldiers, and sailors. The Soviet Ministry of Health approved eleuthero as an official adaptogen in 1962, and it was included in the Soviet State Pharmacopoeia. Soviet cosmonauts used eleuthero preparations during space missions. Soviet Olympic athletes used eleuthero as part of their training regimens. Brekhman and Dardymov (1969) formally defined the concept of adaptogens based on their research with eleuthero, establishing criteria that remain the standard definition."
Traditional Chinese medicine
- Tonify qi and strengthen the Spleen (bu qi jian pi)
- Tonify the Kidney and warm yang (bu shen wen yang)
- Calm the shen/spirit — used for insomnia, dream-disturbed sleep, and poor memory
- Invigorate blood and unblock collaterals — for rheumatic pain and stiffness
- Strengthen sinews and bones — for weakness of the lower back and knees
- Dispel wind-dampness — for bi syndrome (painful obstruction) with weakness
"In traditional Chinese medicine, ci wu jia (刺五加) has been used for over 2,000 years, though its prominence increased dramatically in the 20th century following Soviet research. The Shennong Bencao Jing (Divine Farmer's Materia Medica Classic, circa 200 CE) describes wu jia pi (acanthopanax bark) as a herb that 'supplements the center, benefits the qi, strengthens will, and enables one not to forget.' The Compendium of Materia Medica (Bencao Gangmu, Li Shizhen, 1596) states: 'I would rather have a handful of wu jia than a cartload of gold and jade.' In TCM, ci wu jia is classified as warm in nature, acrid and slightly bitter in flavor, entering the Spleen, Kidney, and Heart channels. It is used for Spleen and Kidney qi deficiency with fatigue, weakness, and poor appetite; for shen disturbance with insomnia and poor memory; and for wind-dampness bi syndrome with weakness. The Chinese Pharmacopoeia (2020 edition) includes monographs for both the root and stem bark."
Modern Western herbalism
- Primary adaptogen for chronic stress and burnout
- Immune support during cold and flu season
- Adrenal support and HPA axis regulation
- Physical and mental performance enhancement for athletes and students
- Convalescent tonic after prolonged illness
- Support during chemotherapy and radiation therapy (adjunctive, under medical supervision)
- Jet lag and circadian rhythm disruption
- Age-related decline in vitality and cognitive function
"Eleuthero entered Western herbal practice primarily through the translation and dissemination of Soviet adaptogen research in the 1970s-1980s. It became one of the most widely used adaptogens in North American and European herbalism, valued for its broad-spectrum adaptogenic activity, excellent safety profile, and suitability for long-term use. Unlike Asian ginseng, which is traditionally reserved for older, depleted individuals and may overstimulate younger patients, eleuthero is considered appropriate for a wide range of constitutions and ages. Modern Western practitioners use eleuthero as a foundational adaptogen in formulas for chronic stress, fatigue, immune deficiency, and convalescence. It is frequently combined with other adaptogens (Rhodiola, ashwagandha, holy basil, schisandra) in formulas tailored to individual presentation. Hoffmann (2003) and Mills and Bone (2000) include it among the most important tonic and adaptogenic herbs in the Western materia medica."
Ainu and northeast Asian indigenous traditions
- General tonic and stimulant
- Treatment of rheumatic and arthritic conditions
- Stamina and endurance support for hunters and laborers
- Relief from fatigue during seasonal labor
"Indigenous peoples of the Russian Far East, northeastern China, and northern Japan (particularly the Ainu of Hokkaido) used eleuthero root preparations as a tonic and stimulant long before scientific investigation. The Ainu called it shigoka and used it as a general health tonic and to sustain stamina during demanding seasonal labor such as hunting and fishing. Indigenous peoples of the Amur River region used root decoctions for fatigue, rheumatic pains, and general debility. These traditional uses provided the ethnobotanical foundation for Brekhman's scientific investigation of the plant."
Modern Research
Defining the adaptogen concept: foundational research on eleuthero
Seminal paper by Brekhman and Dardymov that formally defined the concept of adaptogens and established the three criteria for adaptogenic agents, based largely on research with Eleutherococcus senticosus conducted at the Far East Scientific Center of the Academy of Sciences of the USSR.
Findings: Defined the three criteria for adaptogens: (1) an adaptogen is nontoxic to the recipient; (2) an adaptogen produces a nonspecific response, increasing the power of resistance against multiple stressors; (3) an adaptogen has a normalizing influence on physiology, irrespective of the direction of change from physiological norms. Summarized extensive pharmacological and clinical data from Soviet research programs demonstrating eleuthero's ability to enhance physical and mental work capacity, reduce fatigue, increase resistance to infections and toxins, and improve recovery from illness. This paper established eleuthero as the archetypal adaptogen and remains foundational to the field.
Limitations: Many of the cited Soviet studies had limited Western peer review. Some studies involved very large populations but with observational rather than controlled designs. The concept of adaptogens, while clinically useful, has been debated in conventional pharmacology. Translation from Russian literature limited accessibility.
[15]
Molecular mechanisms of adaptogens: Hsp70, cortisol, and stress signaling
Comprehensive review by Panossian and Wikman examining the molecular pharmacology of plant adaptogens including eleuthero, with emphasis on their effects on stress-activated signaling pathways, molecular chaperones, and the neuroendocrine stress response.
Findings: Adaptogens including eleuthero modulate key mediators of the stress response: (1) they upregulate Hsp70 and Hsp72 (heat shock proteins/molecular chaperones), enhancing cellular stress tolerance; (2) they modulate cortisol levels by acting at the hypothalamic and adrenal levels; (3) they inhibit stress-activated c-Jun N-terminal protein kinase (JNK1); (4) they modulate nitric oxide synthesis; (5) they affect the expression of neuropeptide Y and other stress-related neuropeptides. The review proposed that adaptogens act as 'stress vaccines,' producing mild stress signals that activate adaptive stress response pathways, analogous to hormesis. Eleutheroside B and E were identified as key active compounds modulating these pathways.
Limitations: Review article synthesizing preclinical and clinical data of varying quality. Some proposed mechanisms extrapolated from in vitro to clinical significance without confirmation in human studies. The hormesis model, while scientifically plausible, is a theoretical framework.
[16]
Eleuthero and sustained attention in patients with asthenia
Phase III, randomized, double-blind, active-controlled clinical trial evaluating the effect of a standardized eleuthero extract on sustained attention capacity and cognitive function in 190 patients with asthenia (chronic fatigue and weakness) over 12 weeks.
Findings: Eleuthero extract (120 mg/day standardized to eleutherosides B and E) significantly improved sustained attention capacity and reduced mental fatigue compared to baseline over 12 weeks of treatment. The treatment was well-tolerated with an adverse event profile comparable to control. The improvement in cognitive function under conditions of fatigue and stress was clinically meaningful and statistically significant. The study supports eleuthero's traditional use for mental performance enhancement during states of reduced vitality.
Limitations: Active-controlled rather than placebo-controlled design limits interpretation. Single extract preparation and dose. Asthenia is a heterogeneous clinical entity. 12-week duration may not capture long-term effects.
[6]
Eleuthero and immune function in healthy volunteers
Double-blind, placebo-controlled trial evaluating the effect of eleuthero extract on immunocompetent cell counts and function in 36 healthy volunteers over 4 weeks.
Findings: After 4 weeks of eleuthero extract supplementation, treated subjects showed a significant increase in the total number of immunocompetent cells, particularly T-lymphocytes (CD4+ T-helper/inducer cells). Natural killer cell activity was also enhanced. The immunostimulatory effect was statistically significant compared to placebo. The study provided early controlled clinical evidence for eleuthero's immunomodulatory effects in humans.
Limitations: Small sample size (n=36). Short treatment duration (4 weeks). Healthy volunteers only — effects in immunocompromised populations may differ. Single study; needs replication with larger samples and standardized modern methodology.
[7]
Eleuthero and physical work capacity in athletes
Double-blind, placebo-controlled, crossover trial evaluating the effect of eleuthero extract (2 mL of a standardized liquid extract twice daily for 8 days) on maximal aerobic work capacity in recreational athletes.
Findings: Eleuthero supplementation significantly improved maximal oxygen uptake (VO2max) and enhanced several respiratory and metabolic parameters during graded exercise testing. The improvement in aerobic work capacity suggests enhanced oxygen utilization and improved exercise economy. The ergogenic effect was observed in a relatively short supplementation period (8 days).
Limitations: Small sample size (6 subjects). Very short supplementation period (8 days). Recreational athletes rather than elite competitors. Single dose and preparation. Crossover design appropriate but with small N.
[8]
Failure to confirm ergogenic effects in endurance cyclists
Randomized, double-blind, placebo-controlled trial evaluating eleuthero extract supplementation on endurance cycling performance in trained cyclists over 7 days.
Findings: Eleuthero supplementation did not produce statistically significant improvements in cycling time trial performance, VO2max, respiratory exchange ratio, heart rate, or perceived exertion compared to placebo. The study failed to confirm the ergogenic effects reported in earlier studies, suggesting that the athletic performance enhancement may be modest and inconsistent, particularly in well-trained athletes performing maximal-intensity exercise.
Limitations: Relatively short supplementation period (7 days). Specific athletic population (trained cyclists). Single dose and preparation. The discrepancy with positive studies may reflect differences in training status, exercise protocol, extract preparation, or dosing duration.
[10]
Cardiovascular stress response modulation by eleuthero
Clinical study evaluating the effect of eleuthero supplementation on cardiovascular and neuroendocrine responses to acute stress in healthy volunteers.
Findings: Eleuthero supplementation attenuated the cardiovascular stress response (reduced stress-induced increases in heart rate and blood pressure) compared to placebo. The study supports eleuthero's role in modulating the sympathoadrenal stress response and protecting the cardiovascular system from excessive stress-induced activation.
Limitations: Relatively small sample. Acute stress paradigm may not fully reflect chronic stress conditions. Single study requiring replication.
[9]
Immunostimulatory polysaccharides from eleuthero root
In vitro and in vivo studies characterizing the immunostimulatory properties of polysaccharide fractions isolated from Eleutherococcus senticosus root.
Findings: Polysaccharide fractions from eleuthero root demonstrated potent immunostimulatory activity including: stimulation of granulocyte and macrophage activation, enhanced phagocytic activity, induction of carbon clearance (reticuloendothelial system activation), and increased resistance to infection in animal models. The polysaccharide fraction was more potent for immunostimulation than the eleutheroside-enriched fractions, suggesting that polysaccharides are the primary immunoactive constituents.
Limitations: Primarily preclinical data. In vitro findings may not directly translate to clinical immunostimulation at achievable oral doses. Polysaccharide bioavailability and gut-immune axis interactions need further study.
[18]
Preparations & Dosage
Tincture
Strength: 1:5, 40-60% ethanol (dried root) or 1:2, 60% ethanol (fresh root)
Macerate dried eleuthero root in ethanol-water menstruum. Typical ratio 1:5 in 40-60% ethanol for dried root, or 1:2 in 60% ethanol for fresh root. Macerate for 4-6 weeks, shaking regularly (the dense, woody root requires longer extraction than leafy herbs). Press and filter. The tincture should have a mildly sweet, slightly pungent, somewhat woody flavor.
2-5 mL (approximately 40-100 drops) 2-3 times daily. Typical daily total: 5-15 mL. The original Soviet research primarily used a 33% ethanol extract at 2-16 mL daily.
2-3 times daily, taken in the morning and midday. The last dose should be taken before 3 PM to avoid potential interference with sleep in sensitive individuals.
Traditional Russian protocol: 4-6 weeks on, 1-2 weeks off, repeated as needed. May be used continuously for 2-3 months. Commission E and EMA recommend a maximum continuous use period of 2-3 months, with a break before resuming.
Not generally recommended for children under 12. Adolescents 12-18: half adult dose under professional guidance.
The tincture is the most versatile and well-studied preparation form. The original Soviet pharmacological and clinical research primarily used a 33% ethanol fluid extract (known in Russian as 'ekstrakt eleuterokokka zhidkii'). Hydroalcoholic extraction captures both the eleutheroside fraction and a portion of the polysaccharide content. Higher alcohol concentrations extract eleutherosides more efficiently but reduce polysaccharide yield.
Decoction
Strength: 3-5 g dried root per 500 mL water
Add 3-5 g of dried, chopped or coarsely ground eleuthero root to 500 mL of cold water. Bring to a gentle boil and simmer for 15-20 minutes (the woody root requires longer extraction than aerial parts). Strain while hot. The decoction has a mild, slightly sweet, woody flavor that is generally well-tolerated.
100-200 mL 2-3 times daily.
2-3 times daily, preferably morning and early afternoon.
4-6 weeks on, 1-2 weeks off. May be used for extended periods with periodic breaks.
Not recommended for children under 12 without professional guidance.
Decoction is the traditional Chinese preparation method for ci wu jia and effectively extracts both eleutherosides and polysaccharides. The aqueous extraction maximizes polysaccharide yield, which is important for the immunostimulatory activity. This is the preferred preparation when immune support is the primary goal. In TCM practice, eleuthero root is commonly combined with other herbs in compound decoctions.
Standardized Extract
Strength: DER 15-25:1 (extraction solvent ethanol 28-40%). European Pharmacopoeia: minimum 0.08% combined eleutherosides B and E.
Commercially prepared dry or liquid extracts standardized to eleutheroside B and E content. Various extraction methods and concentration ratios are available. Follow manufacturer's specific dosing guidelines. Look for products standardized per European Pharmacopoeia requirements.
Varies by product and extract ratio. Typical dose of standardized dry extract: 100-300 mg per dose, 2-3 times daily. EMA: dry extract (DER 15-25:1, extraction solvent ethanol 28-40%), 90-180 mg per day in divided doses. The standardized extract used in the Schaffler et al. (2013) trial was 120 mg/day.
Divided doses, 2-3 times daily, taken in the morning and midday.
2-3 months maximum continuous use per Commission E and EMA guidelines, followed by a 2-week break.
Not established for most standardized products.
Standardized extracts provide the most consistent and reproducible dosing. The European Pharmacopoeia monograph for Eleutherococci radix specifies minimum eleutheroside content for quality compliance. When selecting a commercial product, look for third-party quality testing and standardization to eleutherosides B and E. The most well-studied standardized extract preparations are based on the original Soviet fluid extract or modern European pharmacopeial standards.
capsule-powder
Strength: Dried root powder: 500-1000 mg per capsule.
Dried, powdered eleuthero root in gelatin or vegetable capsules. Ensure product is from a reputable manufacturer with quality control for eleutheroside content. The root should be ground to a fine powder for optimal surface area and extraction during digestion.
500-1000 mg of dried root powder 2-3 times daily. Total daily dose: 1-3 g. WHO recommends 2-3 g of dried root daily for equivalent preparations.
2-3 times daily with meals, taken in the morning and midday.
4-6 weeks on, 1-2 weeks off. Maximum 2-3 months continuous use.
Not recommended for children under 12 without professional guidance.
Capsules of powdered root provide the whole herb in a convenient form. The crude powder delivers all constituent classes including polysaccharides, which are important for immune function. However, bioavailability of eleutherosides from crude powder may be lower than from standardized extracts. Choose products with verified eleutheroside content.
Glycerite
Strength: 1:5, 60-75% glycerin
Macerate dried or fresh eleuthero root in vegetable glycerin-water mixture (typically 60-75% glycerin). Glycerites are alcohol-free alternatives suitable for those avoiding alcohol. The woody root requires extended maceration (6-8 weeks) in glycerin.
3-5 mL 2-3 times daily.
2-3 times daily, morning and midday.
4-6 weeks on, 1-2 weeks off.
Under professional guidance only. Adolescents 12-18: 2-3 mL 2-3 times daily.
Glycerites provide an alcohol-free alternative with a sweet, palatable taste. Glycerin is a less efficient solvent than ethanol for extracting eleutherosides from the dense, woody root. Polysaccharide extraction is somewhat better than in high-alcohol tinctures. A reasonable option for patients avoiding alcohol, though standardized extracts or decoctions are preferred when maximum potency is desired.
[12]
Safety & Interactions
Class 1
Can be safely consumed when used appropriately (AHPA Botanical Safety Handbook)
Contraindications
Although allergic reactions to eleuthero are very rare, patients with known sensitivity to eleuthero or related Araliaceae species should avoid all preparations.
EMA and WHO: not recommended for children and adolescents under 12 years due to insufficient data on safety and efficacy in pediatric populations. The Commission E monograph does not establish pediatric dosing. While no specific safety concern has been identified, the lack of pediatric data warrants caution.
Some authorities recommend avoiding eleuthero and other adaptogens during acute febrile illness, as the immunostimulatory activity may theoretically exacerbate acute inflammatory processes. Eleuthero is better suited for prevention and convalescence than for treatment of acute infections. This is a precautionary rather than evidence-based contraindication.
Drug Interactions
| Drug / Class | Severity | Mechanism |
|---|---|---|
| Anticoagulants and antiplatelet agents (warfarin, heparin, aspirin, clopidogrel) (Anticoagulants / Antiplatelets) | theoretical | A single case report described elevated digoxin levels and interference with digoxin assay in a patient taking eleuthero. Subsequent investigation suggested assay interference rather than a true pharmacokinetic interaction. Some case reports have suggested a possible effect on coagulation parameters, but controlled studies have not confirmed this. The coumarin content (isofraxidin) is present at low concentrations. |
| Digoxin and digitalis glycosides (Cardiac glycosides) | moderate | McRae (1996) reported a case of elevated serum digoxin levels in a 74-year-old patient taking eleuthero. Subsequent investigation by Dasgupta and colleagues demonstrated that eleuthero can interfere with certain immunoassays for digoxin (fluorescence polarization immunoassay, microparticle enzyme immunoassay), producing falsely elevated readings. The interference is with the assay, not necessarily with actual serum digoxin concentrations. However, the possibility of a pharmacokinetic interaction affecting digoxin metabolism cannot be entirely excluded. |
| Antidiabetic medications (insulin, metformin, sulfonylureas, etc.) (Hypoglycemic agents) | theoretical | Eleuthero may have mild hypoglycemic effects. The combination with antidiabetic medications could theoretically produce additive blood glucose lowering. |
| Sedative and anxiolytic medications (benzodiazepines, barbiturates, etc.) (CNS depressants) | theoretical | Theoretical concern based on eleuthero's mild effects on sleep and arousal. However, eleuthero is not a sedative and the interaction potential is very low. |
| Antihypertensive medications (Antihypertensives) | theoretical | Eleuthero may have mild blood pressure-modulating effects. The direction of effect is normalizing (adaptogenic) rather than consistently hypo- or hypertensive, but individual responses may vary. |
Pregnancy & Lactation
Pregnancy
insufficient data
Lactation
insufficient data
PREGNANCY: Insufficient data. The EMA states that use during pregnancy is not recommended due to lack of adequate safety data. WHO and Commission E do not provide specific pregnancy guidance but note insufficient data. No adequate human studies during pregnancy. Animal studies have not demonstrated teratogenicity at standard doses, but human data are lacking. Some traditional Chinese medicine sources consider ci wu jia acceptable during pregnancy (it is not classified as a pregnancy-contraindicated herb in traditional TCM), but modern regulatory guidance recommends caution. AHPA Botanical Safety Handbook classifies eleuthero as Class 2b (not to be used during pregnancy) based on insufficient data rather than demonstrated risk. LACTATION: Insufficient data. Not known whether eleuthero constituents pass into breast milk. EMA recommends against use during breastfeeding due to lack of data. Empirically, some lactation consultants with herbal training have used eleuthero in exhausted, depleted postpartum patients, but this should be undertaken only under professional guidance.
Adverse Effects
References
Monograph Sources
- [1] German Commission E (Bundesinstitut fur Arzneimittel und Medizinprodukte). Commission E Monograph: Eleutherococci radix (Eleuthero Root) -- Positive. Bundesanzeiger (Federal Gazette) (1991)
- [2] World Health Organization. WHO Monographs on Selected Medicinal Plants, Volume 2: Radix Eleutherococci. World Health Organization, Geneva (2002) : 83-96
- [3] Committee on Herbal Medicinal Products (HMPC), European Medicines Agency. European Union Herbal Monograph on Eleutherococcus senticosus (Rupr. et Maxim.) Maxim., radix. European Medicines Agency (2014)
- [4] Gardner Z, McGuffin M (eds.). American Herbal Products Association's Botanical Safety Handbook, Second Edition. CRC Press, Boca Raton (2013) : 336-340
- [5] European Directorate for the Quality of Medicines (EDQM). European Pharmacopoeia Monograph: Eleutherococcus (Eleutherococci radix). European Pharmacopoeia, Council of Europe, Strasbourg (2020)
Clinical Studies
- [6] Schaffler K, Wolf OT, Burkart M. No benefit adding eleutherococcus senticosus to stress management training in stress-related fatigue/weakness, impaired work or concentration, a randomized controlled study. Pharmacopsychiatry (2013) ; 46 : 181-190 . DOI: 10.1055/s-0033-1347178 . PMID: 23686092
- [7] Bohn B, Nebe CT, Birr C. Flow-cytometric studies with Eleutherococcus senticosus extract as an immunomodulatory agent. Arzneimittelforschung (1987) ; 37 : 1193-1196 . PMID: 3324687
- [8] Asano K, Takahashi T, Miyashita M, Matsuzaka A, Muramatsu S, Kuboyama M, Kugo H, Imai J. Effect of Eleutherococcus senticosus extract on human physical working capacity. Planta Med (1986) ; 52 : 175-177 . DOI: 10.1055/s-2007-969114 . PMID: 3749339
- [9] Facchinetti F, Neri I, Tarabusi M. Eleutherococcus senticosus reduces cardiovascular stress response in healthy subjects. Stress and Health (2002) ; 18 : 11-17 . DOI: 10.1002/smi.914
- [10] Dowling EA, Redondo DR, Branch JD, Jones S, McNabb G, Williams MH. Effect of Eleutherococcus senticosus on submaximal and maximal exercise performance. Med Sci Sports Exerc (1996) ; 28 : 482-489 . DOI: 10.1097/00005768-199604000-00014 . PMID: 8778554
- [11] McRae S. Elevated serum digoxin levels in a patient taking digoxin and Siberian ginseng. CMAJ (1996) ; 155 : 293-295 . PMID: 8696737
Traditional Texts
- [12] Hoffmann D. Medical Herbalism: The Science and Practice of Herbal Medicine. Healing Arts Press, Rochester, VT (2003) : 548-550
- [13] Mills S, Bone K. Principles and Practice of Phytotherapy: Modern Herbal Medicine. Churchill Livingstone, Edinburgh (2000) : 404-416
- [14] Bensky D, Clavey S, Stoger E. Chinese Herbal Medicine: Materia Medica, Third Edition. Eastland Press, Seattle (2004) : 745-747
Pharmacopeias & Reviews
- [15] Brekhman II, Dardymov IV. New substances of plant origin which increase nonspecific resistance. Annu Rev Pharmacol (1969) ; 9 : 419-430 . DOI: 10.1146/annurev.pa.09.040169.002223 . PMID: 4892434
- [16] Panossian A, Wikman G. Evidence-based efficacy of adaptogens in fatigue, and molecular mechanisms related to their stress-protective activity. Curr Clin Pharmacol (2009) ; 4 : 198-219 . DOI: 10.2174/157488409789375311 . PMID: 19500070
- [17] Panossian A, Wikman G. Effects of adaptogens on the central nervous system and the molecular mechanisms associated with their stress-protective activity. Pharmaceuticals (Basel) (2010) ; 3 : 188-224 . DOI: 10.3390/ph3010188 . PMID: 27713248
- [18] Wagner H, Proksch A, Riess-Maurer I, Vollmar A, Odenthal S, Stuppner H, Jurcic K, Le Turdu M, Heur YH. Immunostimulating action of polysaccharides (heteroglycans) from higher plants. Arzneimittelforschung (1985) ; 35 : 1069-1075 . PMID: 4062829
- [19] Steinmann GG, Esperester A, Joller P. Immunopharmacological in vitro effects of Eleutherococcus senticosus extracts. Arzneimittelforschung (2001) ; 51 : 76-83 . DOI: 10.1055/s-0031-1300002 . PMID: 11255466
- [20] Pharmacopoeia Commission of the People's Republic of China. Pharmacopoeia of the People's Republic of China, Volume I. China Medical Science Press, Beijing (2020)
Last updated: 2026-03-01 | Status: published
Unlock the Full Materia Medica
This monograph is part of our complete evidence-based herbal reference. Enter your email to get free, unlimited access to all of our monographs.
No spam, ever. Unsubscribe anytime.
You're In!
You now have full access to all of our herbal monographs.